Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|February 5, 2011
Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) LigandsSabrina Taliani, Isabella Pugliesi, Federico Da Settimo
Current Topics in Medicinal Chemistry|April 8, 2010
A3 receptor ligands: past, present and future trendsSabrina Taliani, Isabella Pugliesi, Marusca Bellandi, et al.
Current Topics in Medicinal Chemistry|December 30, 2011
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effectsFrancesca Simorini, Anna Maria Marini, Sabrina Taliani, et al.
ACS Chemical Neuroscience|August 4, 2012
3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effectsAlessia Scatena, Francesco Fornai, Maria Letizia Trincavelli, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Arylthioamides as H2S Donors: l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in VivoAlma Martelli, Lara Testai, Valentina Citi, et al.
Biochimica Et Biophysica Acta|December 24, 2013
Allosteric modulators of human A2B adenosine receptorMaria Letizia Trincavelli, Chiara Giacomelli, Simona Daniele, et al.
European Journal of Medicinal Chemistry|October 1, 2013
Modulation of A2B adenosine receptor by 1-Benzyl-3-ketoindole derivativesSabrina Taliani, Maria Letizia Trincavelli, Barbara Cosimelli, et al.
Journal of Medicinal Chemistry|April 12, 2012
Synthesis and biological evaluation of 4-phenylquinazoline-2-carboxamides designed as a novel class of potent ligands of the translocator proteinSabrina Castellano, Sabrina Taliani, Ciro Milite, et al.
Journal of Medicinal Chemistry|May 5, 2010
Novel irreversible fluorescent probes targeting the 18 kDa translocator protein: synthesis and biological characterizationSabrina Taliani, Eleonora Da Pozzo, Marusca Bellandi, et al.
Chemmedchem|July 29, 2011
Derivatives of benzimidazol-2-ylquinoline and benzimidazol-2-ylisoquinoline as selective A1 adenosine receptor antagonists with stimulant activity on human colon motilityBarbara Cosimelli, Sabrina Taliani, Giovanni Greco, et al.
Pageof 2